Annual Accounts Payable
$14.50 M
+$8.29 M+133.62%
31 December 2023
Summary:
Trinity Biotech annual accounts payable is currently $14.50 million, with the most recent change of +$8.29 million (+133.62%) on 31 December 2023. During the last 3 years, it has risen by +$7.39 million (+104.08%). TRIB annual accounts payable is now -41.50% below its all-time high of $24.78 million, reached on 31 December 2007.TRIB Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$25.31 M
+$2.23 M+9.68%
30 September 2024
Summary:
Trinity Biotech quarterly accounts payable is currently $25.31 million, with the most recent change of +$2.23 million (+9.68%) on 30 September 2024. Over the past year, it has increased by +$14.68 million (+138.17%). TRIB quarterly accounts payable is now -18.05% below its all-time high of $30.88 million, reached on 31 March 2021.TRIB Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TRIB Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +133.6% | +138.2% |
| 3 y3 years | +104.1% | +38.1% |
| 5 y5 years | +78.6% | +25.7% |
TRIB Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +133.6% | at high | +551.4% |
| 5 y | 5 years | at high | +133.6% | -18.1% | +551.4% |
| alltime | all time | -41.5% | +4732.0% | -18.1% | +8336.0% |
Trinity Biotech Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $25.31 M(+9.7%) |
| June 2024 | - | $23.07 M(+12.4%) |
| Mar 2024 | - | $20.53 M(+428.4%) |
| Dec 2023 | $14.50 M(+133.6%) | $3.88 M(-63.4%) |
| Sept 2023 | - | $10.63 M(-15.5%) |
| June 2023 | - | $12.57 M(-2.6%) |
| Mar 2023 | - | $12.91 M(+108.1%) |
| Dec 2022 | $6.21 M(-8.3%) | $6.21 M(-57.0%) |
| Sept 2022 | - | $14.45 M(+22.6%) |
| June 2022 | - | $11.78 M(-24.7%) |
| Mar 2022 | - | $15.64 M(+131.2%) |
| Dec 2021 | $6.76 M(-4.8%) | $6.76 M(-63.1%) |
| Sept 2021 | - | $18.32 M(-14.0%) |
| June 2021 | - | $21.30 M(-31.0%) |
| Mar 2021 | - | $30.88 M(+334.8%) |
| Dec 2020 | $7.10 M(-9.3%) | $7.10 M(-68.1%) |
| Sept 2020 | - | $22.28 M(-0.2%) |
| June 2020 | - | $22.33 M(+3.2%) |
| Mar 2020 | - | $21.64 M(+176.3%) |
| Dec 2019 | $7.83 M(-3.5%) | $7.83 M(-61.1%) |
| Sept 2019 | - | $20.14 M(+9.0%) |
| June 2019 | - | $18.47 M(-5.9%) |
| Mar 2019 | - | $19.64 M(+142.0%) |
| Dec 2018 | $8.12 M(+0.9%) | $8.12 M(-60.8%) |
| Sept 2018 | - | $20.68 M(+0.9%) |
| June 2018 | - | $20.49 M(-5.8%) |
| Mar 2018 | - | $21.76 M(+170.5%) |
| Dec 2017 | $8.04 M(-10.8%) | $8.04 M(-64.9%) |
| Sept 2017 | - | $22.92 M(+1.6%) |
| June 2017 | - | $22.57 M(+8.0%) |
| Mar 2017 | - | $20.89 M(+131.7%) |
| Dec 2016 | $9.02 M(+8.3%) | $9.02 M(-54.9%) |
| Sept 2016 | - | $19.98 M(+3.1%) |
| June 2016 | - | $19.38 M(+1.0%) |
| Mar 2016 | - | $19.20 M(+130.5%) |
| Dec 2015 | $8.33 M(-12.0%) | $8.33 M(-55.4%) |
| Sept 2015 | - | $18.69 M(-5.4%) |
| June 2015 | - | $19.76 M(-1.8%) |
| Mar 2015 | - | $20.12 M(+112.4%) |
| Dec 2014 | $9.47 M(+16.1%) | $9.47 M(-37.5%) |
| Sept 2014 | - | $15.15 M(-5.9%) |
| June 2014 | - | $16.11 M(+2.7%) |
| Mar 2014 | - | $15.68 M(+92.3%) |
| Dec 2013 | $8.15 M(+80.2%) | $8.15 M(-62.2%) |
| Sept 2013 | - | $21.59 M(+61.8%) |
| June 2013 | - | $13.34 M(+3.0%) |
| Mar 2013 | - | $12.96 M(+186.3%) |
| Dec 2012 | $4.53 M(+19.2%) | $4.53 M(-61.6%) |
| Sept 2012 | - | $11.79 M(+0.2%) |
| June 2012 | - | $11.77 M(+16.4%) |
| Mar 2012 | - | $10.10 M(+166.1%) |
| Dec 2011 | $3.80 M | $3.80 M(-66.7%) |
| Sept 2011 | - | $11.41 M(-6.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2011 | - | $12.15 M(-4.2%) |
| Mar 2011 | - | $12.68 M(+10.8%) |
| Dec 2010 | $11.45 M(-10.9%) | $11.45 M(-10.8%) |
| Sept 2010 | - | $12.83 M(+4.8%) |
| June 2010 | - | $12.24 M(+4.3%) |
| Mar 2010 | - | $11.73 M(-8.7%) |
| Dec 2009 | $12.84 M(-44.1%) | $12.84 M(-24.0%) |
| Sept 2009 | - | $16.91 M(-12.3%) |
| June 2009 | - | $19.28 M(+3.2%) |
| Mar 2009 | - | $18.68 M(-18.7%) |
| Dec 2008 | $22.97 M(-7.3%) | $22.97 M(+8.3%) |
| Sept 2008 | - | $21.21 M(-2.0%) |
| June 2008 | - | $21.65 M(-8.4%) |
| Mar 2008 | - | $23.63 M(-4.6%) |
| Dec 2007 | $24.78 M(+219.6%) | $24.78 M(+25.6%) |
| June 2007 | - | $19.73 M(-3.9%) |
| Mar 2007 | - | $20.54 M(+165.0%) |
| Dec 2006 | $7.75 M(+27.8%) | $7.75 M(-59.9%) |
| Sept 2006 | - | $19.34 M(+31.3%) |
| June 2006 | - | $14.73 M(+30.7%) |
| Mar 2006 | - | $11.27 M(+85.8%) |
| Dec 2005 | $6.07 M(+82.2%) | $6.07 M(-61.6%) |
| Sept 2005 | - | $15.80 M(+56.1%) |
| June 2005 | - | $10.13 M(+13.6%) |
| Mar 2005 | - | $8.92 M(+167.9%) |
| Dec 2004 | $3.33 M(-5.4%) | $3.33 M(-78.0%) |
| Sept 2004 | - | $15.11 M(+5.4%) |
| June 2004 | - | $14.33 M(-19.2%) |
| Mar 2004 | - | $17.74 M(+404.2%) |
| Dec 2003 | $3.52 M(+14.2%) | $3.52 M(-75.8%) |
| Sept 2003 | - | $14.54 M(-11.1%) |
| June 2003 | - | $16.35 M(-15.0%) |
| Mar 2003 | - | $19.24 M(+524.6%) |
| Dec 2002 | $3.08 M(+79.7%) | $3.08 M(-77.6%) |
| Sept 2002 | - | $13.73 M(+16.1%) |
| June 2002 | - | $11.84 M(-8.7%) |
| Mar 2002 | - | $12.96 M(+656.1%) |
| Dec 2001 | $1.71 M(-60.0%) | $1.71 M(-78.1%) |
| Sept 2001 | - | $7.84 M(-14.6%) |
| June 2001 | - | $9.18 M(-1.7%) |
| Mar 2001 | - | $9.35 M(+118.0%) |
| Dec 2000 | $4.29 M(+81.1%) | $4.29 M(+81.1%) |
| Dec 1999 | $2.37 M(-9.0%) | $2.37 M(-87.2%) |
| Sept 1999 | - | $18.50 M(-5.6%) |
| June 1999 | - | $19.60 M(+21.0%) |
| Mar 1999 | - | $16.20 M(+523.1%) |
| Dec 1998 | $2.60 M(-31.6%) | $2.60 M(-77.4%) |
| Sept 1998 | - | $11.50 M(+202.6%) |
| Dec 1997 | $3.80 M(+153.3%) | $3.80 M(+153.3%) |
| Dec 1996 | $1.50 M(+400.0%) | $1.50 M(+400.0%) |
| Dec 1995 | $300.00 K(-40.0%) | $300.00 K(-70.0%) |
| Dec 1994 | $500.00 K(-50.0%) | - |
| Feb 1994 | - | $1.00 M |
| Feb 1994 | $1.00 M | - |
FAQ
- What is Trinity Biotech annual accounts payable?
- What is the all time high annual accounts payable for Trinity Biotech?
- What is Trinity Biotech annual accounts payable year-on-year change?
- What is Trinity Biotech quarterly accounts payable?
- What is the all time high quarterly accounts payable for Trinity Biotech?
- What is Trinity Biotech quarterly accounts payable year-on-year change?
What is Trinity Biotech annual accounts payable?
The current annual accounts payable of TRIB is $14.50 M
What is the all time high annual accounts payable for Trinity Biotech?
Trinity Biotech all-time high annual accounts payable is $24.78 M
What is Trinity Biotech annual accounts payable year-on-year change?
Over the past year, TRIB annual accounts payable has changed by +$8.29 M (+133.62%)
What is Trinity Biotech quarterly accounts payable?
The current quarterly accounts payable of TRIB is $25.31 M
What is the all time high quarterly accounts payable for Trinity Biotech?
Trinity Biotech all-time high quarterly accounts payable is $30.88 M
What is Trinity Biotech quarterly accounts payable year-on-year change?
Over the past year, TRIB quarterly accounts payable has changed by +$14.68 M (+138.17%)